Literature DB >> 7615801

Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

R W Thompson1, D R Holmes, R A Mertens, S Liao, M D Botney, R P Mecham, H G Welgus, W C Parks.   

Abstract

Abdominal aortic aneurysms (AAA) are characterized by disruption and degradation of the elastic media, yet the elastolytic proteinases involved and their cellular sources are undefined. We examined if 92-kD gelatinase, an elastolytic matrix metalloproteinase, participates in the pathobiology of AAA. Gelatin zymography of conditioned medium from normal, atheroocclusive disease (AOD), or AAA tissues in organ culture showed that all tissues produced 72-kD gelatinase. AOD and AAA cultures also secreted 92-kD gelatinase, but significantly more enzyme was released from AAA tissues. ELISA confirmed that AAA tissues released approximately 2-fold more 92-kD gelatinase than AOD tissue and approximately 10-fold more than normal aorta. Phorbol ester induced a 5.3-fold increase in 92-kD gelatinase secretion by normal aorta and AOD and an 11.5-fold increase by AAA. By immunohistochemistry, 92-kD gelatinase was not detected in normal aorta and was only occasionally seen within the neointimal lesions of AOD tissue. In all AAA specimens, however, 92-kD gelatinase was readily localized to numerous macrophages in the media and at the adventitial-medial junction. The expression of 92-kD gelatinase mRNA by aneurysm-infiltrating macrophages was confirmed by in situ hybridization. These results demonstrate that diseased aortic tissues secrete greater amounts of gelatinolytic activity than normal aorta primarily due to increased production of 92-kD gelatinase. In addition, the localization of 92-kD gelatinase to macrophages in the damaged wall of aneurysmal aortas suggests that chronic release of this elastolytic metalloproteinase contributes to extracellular matrix degradation in AAA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615801      PMCID: PMC185203          DOI: 10.1172/JCI118037

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Recommended indications for operative treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery.

Authors:  L H Hollier; L M Taylor; J Ochsner
Journal:  J Vasc Surg       Date:  1992-06       Impact factor: 4.268

2.  Are aortic aneurysms caused by atherosclerosis?

Authors:  D Reed; C Reed; G Stemmermann; T Hayashi
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

Review 3.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

4.  The role of inflammation in nonspecific abdominal aortic aneurysm disease.

Authors:  C M Brophy; J M Reilly; G J Smith; M D Tilson
Journal:  Ann Vasc Surg       Date:  1991-05       Impact factor: 1.466

5.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms.

Authors:  G S Herron; E Unemori; M Wong; J H Rapp; M H Hibbs; R J Stoney
Journal:  Arterioscler Thromb       Date:  1991 Nov-Dec

7.  Metalloproteinases in degenerative aortic disease.

Authors:  N Vine; J T Powell
Journal:  Clin Sci (Lond)       Date:  1991-08       Impact factor: 6.124

8.  Aneurysm or occlusive disease--factors determining the clinical course of atherosclerosis of the infrarenal aorta.

Authors:  G S McGee; B T Baxter; V P Shively; R Chisholm; W J McCarthy; W R Flinn; J S Yao; W H Pearce
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

9.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries.

Authors:  M D Botney; L R Kaiser; J D Cooper; R P Mecham; D Parghi; J Roby; W C Parks
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

Authors:  G I Goldberg; A Strongin; I E Collier; L T Genrich; B L Marmer
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more
  107 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 2.  A confederacy of proteinases.

Authors:  William C Parks
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Authors:  Koichi Shimizu; Masayoshi Shichiri; Peter Libby; Richard T Lee; Richard N Mitchell
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 4.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

5.  Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: from the Dallas Heart Study.

Authors:  Justin L Grodin; Tiffany M Powell-Wiley; Colby R Ayers; Darpan S Kumar; Anand Rohatgi; Amit Khera; Darren K McGuire; James A de Lemos; Sandeep R Das
Journal:  Vasc Med       Date:  2011-10       Impact factor: 3.239

6.  Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA).

Authors:  Martina Ramella; Francesca Boccafoschi; Kevin Bellofatto; Antonia Follenzi; Luca Fusaro; Renzo Boldorini; Francesco Casella; Carla Porta; Piergiorgio Settembrini; Mario Cannas
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

7.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

8.  Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2.

Authors:  Chunmao Wang; Xiangyang Qian; Xiaogang Sun; Qian Chang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-11

9.  CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice.

Authors:  Hui-fang Zhou; Huimin Yan; Judy L Cannon; Luke E Springer; Jonathan M Green; Christine T N Pham
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

10.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.